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Abstract
New de novo sources of omega 3 (n-3) long chain polyunsaturated fatty acids (LC-PUFA)
are required as alternatives to fish oil in aquafeeds in order to maintain adequate levels of
the beneficial fatty acids, eicosapentaenoic and docosahexaenoic (EPA and DHA, respec-
tively). The present study investigated the use of an EPA+DHA oil derived from transgenic
Camelina sativa in Atlantic salmon (Salmo salar) feeds containing low levels of fishmeal
(35%) and fish oil (10%), reflecting current commercial formulations, to determine the
impacts on tissue fatty acid profile, intestinal transcriptome, and health of farmed salmon.
Post-smolt Atlantic salmon were fed for 12-weeks with one of three experimental diets con-
taining either a blend of fish oil/rapeseed oil (FO), wild-type camelina oil (WCO) or trans-
genic camelina oil (DCO) as added lipid source. The DCO diet did not affect any of the fish
performance or health parameters studied. Analyses of the mid and hindgut transcriptomes
showed only mild effects on metabolism. Flesh of fish fed the DCO diet accumulated almost
double the amount of n-3 LC-PUFA than fish fed the FO or WCO diets, indicating that these
oils from transgenic oilseeds offer the opportunity to increase the n-3 LC-PUFA in farmed
fish to levels comparable to those found a decade ago.
Introduction
It is widely recognized that the omega-3 (n-3) long-chain polyunsaturated fatty acids
(LC-PUFA), eicosapentaenoic (EPA, 20:5n-3) and docosahexaenoic (DHA; 22:6n-3) acids,
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have beneficial health effects for humans [1–3]. Consequently, many organisations have pub-
lished recommended daily intakes of EPA and DHA for human consumers (e.g. [4–5]).
Although marine microalgae are the main producers of these fatty acids [6], they are accumu-
lated through the marine trophic chain and, therefore, fish and seafood products are the main
sources of n-3 LC-PUFA in human diets. Indeed, with traditional capture fisheries stagnating,
aquaculture is the best option to provide these healthy fatty acids as farmed products
accounted for up to 73.8 million tons of fish and seafood in 2014 [7] contributing to global n-3
LC-PUFA supply. However, fish meal and fish oil are major raw materials employed in the for-
mulation of aquafeeds, and there is gap between the supply and demand of these marine
resources, which are finite and limited on an annual basis [8]. Therefore, this has dictated that
they must be increasingly replaced in feeds by alternatives including plant meals and vegetable
oils. Therefore, modern, sustainable aquafeeds contain increasing levels of these terrestrial
agriculture alternatives that contain no LC-PUFA, which has translated into a substantial
reduction in the content of EPA and DHA in the flesh of farmed fish such as salmon over the
last decade [9].
Recently, new de novo sources of n-3 LC-PUFA has been developed from an oilseed crop,
Camelina sativa, genetically modified to synthesize either EPA or EPA+ DHA [10]. Two such
oils have been evaluated as replacements for fish oil in feeds for Atlantic salmon (Salmo salar)
[11–13] and gilthead sea bream (Sparus aurata) [14], as well as mice [15]. In all the fish feeding
trials the use of the new GM-derived oils supported comparable growth performance as well as
enhanced deposition of n-3 LC-PUFA in flesh compared to fish fed diets containing wild-type
camelina oil. However, fish did not accumulate as high levels of these essential fatty acids as fish
fed diets containing 100% fish oil as the single lipid source. The control diets in the previous tri-
als were “gold standard” having high levels of fishmeal and fish oil such that the levels of total n-
3 LC-PUFA (including 20:4n-3 and 22:5n-3) were in excess of 20% of total fatty acids, far higher
that the EPA+DHA content in current salmon feeds in Norway (around 6% of total fatty acids).
Therefore, while the feeds in the previous trials were formulated to test the ability of the new
oils to support growth at the same level as in “ideal” high marine feeds, they did not reflect pres-
ent sustainable feed formulations with high levels of plant proteins and vegetable oils.
In the present trial, the efficacy of the oil containing both EPA and DHA from transgenic
Camelina sativa was evaluated in Atlantic salmon feeds reflecting current commercial formu-
lations. Thus, feeds were formulated with much lower levels of fishmeal than previously and a
1:1 blend of fish oil and vegetable oil, specifically rapeseed oil, was used in the positive control
feed to reflect current practice. The effects of this new de novo source of EPA and DHA on fish
performance, tissue fatty acid profiles, liver and intestine morphology, liver gene expression as
well as mid and hindgut transcriptome were determined. In addition, the effect of an environ-
mental stressor (chasing) on several fish blood and plasma parameters was evaluated.
Materials and methods
Production of oil from transgenic Camelina sativa
A construct containing a cassette of seven genes optimized for EPA and DHA synthesis (a
Δ6-desaturase from Ostococcus tauri (OtΔ6), a Δ6 fatty acid elongase from Physcomitrella
patens (PSE1) a Δ5-desaturase from Thraustochytrium sp. (TcΔ5), a Δ12-desaturase from
Phytophthora sojae (PsΔ12), an ω3-desaturase from Phytophthora infestans (Pi- ω3), a
Δ5-elongase from O. tauri and a Δ4-desaturase from Emiliania huxleyi) was used for trans-
formation as described previously [10]. Seeds harvested from transformed plants were illu-
minated with green LED light and fluorescent seeds identified using a red lens filter. No
obvious phenotypic perturbation was observed as a result of modification of the seed oil
EPA and DHA GM-Camelina oil for salmon aquafeeds
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composition. Full details are provided in [10]. C. sativa was grown in a containment glass-
house at 23˚C day/16˚C night. Oil was extracted from seeds by cold-pressing and solvent
extraction to maximize yield (PPM, Magdeburg, Germany), and stabilized by the addition of
the anti-oxidant ethoxyquin (300 ppm).
Table 1. Proximate and fatty acid compositions (percentage of fatty acids) of the three experimental
feeds.
FO WCO DCO
Feed ingredients (%)
Fish meal 35.0 35.0 35.0
Soy protein concentrate (60%) 12.4 12.4 12.4
Wheat gluten 5.0 5.0 5.0
Maize gluten 12.0 12.0 12.0
Wheat 14.0 14.0 14.0
Fish oil 10 - -
Rapeseed oil 10 - -
Wild-type Camelina oil - 20 -
EPA+DHA-Camelina oil - - 20
Vitamins/Minerals 1.6 1.6 1.6
Amino acids 0.7 0.7 0.7
Yttrium oxide 0.1 0.1 0.1
Analysed composition
Dry matter (%) 93.8 92.2 93.9
Protein (%) 45.2 45.8 44.9
Fat (%) 22.7 19.1 19.4
Ash 7.5 7.5 7.7
Fatty acid composition (%)
Total saturated1 12.4 16.6 17.4
Total monoenes2 49.4 31.3 19.8
18:2n-6 11.7 12.5 12.8
20:2n-6 0.1 1.7 0.8
20:3n-6 n.d. n.d. 1.2
20:4n-6 0.2 n.d. 1.8
Total n-6 PUFA3 19.7 20.5 25.6
18:3n-3 3.7 30.2 14.0
20:3n-3 n.d. 1.2 0.7
20:4n-3 0.2 n.d. 2.6
20:5n-3 3.1 1.2 6.3
22:5n-3 0.3 n.d. 1.5
22:6n-3 2.8 2.0 6.3
Total n-3 PUFA4 11.0 34.9 33.8
Total PUFA 30.8 55.3 59.3
Total n-3 LC-PUFA 6.4 3.2 16.7
1Contains 14:0, 16:0, 18:0, 20:0, 22:0 and 24:0;
2Contains 16:1n-7, 18:1n-9, 18:1n-7, 20:1n-9, 22:1n-11 and 22:1n-9;
3Contains 18:2n-6;
4Contains 18:4n-3.
DCO, feed containing EPA+DHA oil from transgenic Camelina; FO, fish oil feed; LC-PUFA, long-chain
polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3 22:5n-3 and 22:6n-3). n.d., not detected; WCO, wild-
type Camelina oil feed.
https://doi.org/10.1371/journal.pone.0175415.t001
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Diets and feeding trial
Three isonitrogenous and isoenergetic diets were formulated to satisfy the nutritional require-
ments of salmon (Table 1). The diets supplied 45 g kg-1 crude protein and 21 g kg-1 crude lipid
and were manufactured at BioMar Tech-Centre (Brande, Denmark). The diets had the same
basal composition with added oil supplied by a 1:1 blend of fish oil/rapeseed oil, wild-type
camelina oil or EPA/DHA-camelina oil and named FO, WCO and DCO, respectively. The
fatty acid profiles of the oils used in the present trial are presented in S1 Table. A total of 342
post-smolt Atlantic salmon with an average body weight of 122.5 ± 0.3 (mean ± S.D.) were dis-
tributed into 9 400 L squared flow-through seawater tanks (38 fish per tank) and fed one of the
three experimental feeds (twice daily) in triplicate for 12 weeks. The experimental tanks were
equipped with lids fitted with 18W fluorescent light tubes and automatic feeders (Arvo-Tec T
drum 2000, www.arvotec.fi), and fish were fed to excess to ensure that feed availability did not
restrict growth. All procedures were approved by the Norwegian Animal Experiment Commit-
tee (Forsøksdyrutvalget), experiment ID.8089.
Stress challenge test and sample collection
After 12 weeks of feeding, blood and tissues were sampled from randomly selected fish following
48 h fasting, either directly (0 h), or 4 h and 24 h after being subjected to an environmental stress
(chasing with a stick for 10 min). At each sampling point fish were killed by overdose with meta-
caine sulphonate (> 150 mg l-1, FINQUEL vet., ScanAqua AS, Årnes, Norway) and blood from
4 fish per tank collected via the caudal vein by 1 ml heparinised syringes fitted with 20G needles
and whole blood used for haematocrit determination prior to the stress (0 h) and at 4 h and 24 h
post challenge. Blood samples were centrifuged at 10,000 g for 3 min to allow blood and plasma
to separate and subsequently frozen on dry ice before storing at -80˚C until further analysis.
Samples of liver, midgut and hindgut from the same four fish used for blood extraction
were collected, stabilised in RNA Later (Sigma, Poole, UK) and stored at -20˚C prior to RNA
extraction. Additionally samples of liver, mid and hindgut sections of intestine from the same
4 fish were dissected and placed in 4% buffered formaldehyde for histopathological evaluation.
The hindgut was dissected from the point where the intestinal diameter increases, the mucosa
becomes darker and rings are clearly observed. Samples of muscle (flesh), liver, brain, head
kidney, midgut and hindgut from a further 3 fish per tank at 0 h were immediately frozen and
stored at– 80˚C prior to lipid and fatty acid analyses. All the remaining fish in the tank (31
fish) were killed by overdose with metacaine sulphonate and measured and weighed at the end
of the stress challenge (24 h).
Proximate composition
Feeds were ground before determination of proximate composition according to standard
procedures [16]. Moisture contents were obtained after drying in an oven at 110˚C for 24 h
and ash content determined after incineration at 600˚C for 16 h. Crude protein content was
measured by determining nitrogen content (N x 6.25) using automated Kjeldahl analysis
(Tecator Kjeltec Auto 1030 analyzer, Foss, Warrington, UK) and crude lipid content deter-
mined gravimetrically after Soxhlet lipid extraction (Tecator Soxtec system 2050 Auto Extrac-
tion apparatus).
Calculations
Biometric parameters were estimated as follows: Fulton’s condition factor (k) = 100  (W/L3),
where W is the final weight (g) and L is the total length (cm). Specific growth rate (SGR) = 100
EPA and DHA GM-Camelina oil for salmon aquafeeds
PLOS ONE | https://doi.org/10.1371/journal.pone.0175415 April 12, 2017 4 / 29
 (lnWo—ln Wf)  D-1, where Wo and Wf are the initial and final weights (tanks means),
respectively, and D represents the number of feeding days.
Plasma analysis
Plasma cortisol analysis was performed by Cortisol Parameter Assay Kits (Cortisol ELISA, RE
52061, IBL, Hamburg, Germany). Plasma ion levels (sodium, potassium, chloride), alkaline
phosphatase, glucose and lactate were analysed by MaxMat PL II (MaxMat, Montpellier,
France). Osmolality was measured by Fiske1 210 Microsample Osmometer (Advanced Instru-
ments Inc. Norwood, MA, USA).
Tissue lipid content and fatty acid composition
Samples of flesh, liver, brain, head kidney, midgut and hindgut from three fish per tank
were prepared as pooled homogenates (n = 3 per treatment) and total lipid extracted from 1
g by homogenizing in chloroform/methanol (2:1, v/v) using an Ultra-Turrax tissue dis-
rupter (Fisher Scientific, Loughborough, UK), and content determined gravimetrically [17].
Fatty acid methyl esters (FAME) were prepared from total lipid by acid-catalyzed transes-
terification at 50˚C for 16 h [18], and FAME extracted and quantified by a gas chromato-
graph (AutoSystem XL, Perkin Elmer, Waltham, MA) with Total Chrom Version 6.3.1
software. The system was equipped with an auto-injector (1 μl, inlet temperature 250˚C)
and a flame ionisation detector (FID, 280˚C). The temperature program for the oven was
90˚C for 1 min, then raised to 150˚C at 30 min-1 and finally raised to 225˚C at 3˚C min-1
and held for 7 min. Helium was used as the carrier gas and a fused silica capillary column
coated with a chemically bonded polyethylene glycol (CP-Wax 52CB, 25 m × 0.25 mm i.d;
Varian, Palo Alto, CA) was used. Individual methyl esters were identified by comparison
with known standards and a well-characterized fish oil, and also by reference to published
data [19].
RNA extraction and cDNA synthesis
Liver, midgut and hindgut from eighteen individual fish per dietary treatment were homoge-
nized in 1 ml of TriReagent1 (Sigma-Aldrich, Dorset, UK), total RNA isolated following man-
ufacturer’s instructions, and quantity and quality determined by spectrophotometry using a
Nanodrop ND-1000 (Labtech Int., East Sussex, UK) and electrophoresis using 200 ng of total
RNA in a 1% agarose gel. Additionally the Agilent Bioanalyzer with the RNA LabChip kit (Agi-
lent Technologies) was used to analyze approximately 300 ng of total RNA from a randomly
selected number of samples (72 samples; 12 samples per treatment and tissue) and provide an
RNA integrity number (RIN), which was higher than 8.0 in all samples (average RIN = 8.2).
cDNA was synthesized as detailed in [20] and samples pooled to obtain n = 6 per dietary
treatment.
Microarray hybridizations and image analysis
Transcriptome analysis of midgut and hindgut was performed using an Atlantic salmon cus-
tom-made oligoarray (ArrayExpress accession number A-MEXP-2065) with 44k features per
array on a four-array-per-slide format (Agilent Technologies UK Ltd., Wokingham, UK). A
dual-label experimental design using 18 microarrays was employed for the microarray hybridi-
zations with Cy3-labelled test samples competitively hybridized to a common Cy5-labelled
pooled-reference per array. The common reference was a pool of equal amounts of amplified
RNA from all test samples.
EPA and DHA GM-Camelina oil for salmon aquafeeds
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Indirect labelling and hybridization were performed as reported previously [11]. Briefly, 250
ng of total RNA were amplified (TargetAmpTM 1-Round Aminoallyl-aRNA Amplification Kit
101. Epicentre, Madison, Wisconsin, USA) and experimental and pooled reference labelled
with Cy3 or Cy5, respectively (GE HealthCare, Little Chalfont, UK). Microarray hybridizations
were performed in SureHyb hybridization chambers in a DNA Microarray Hybridization Oven
(Agilent Technologies) with 825 ng of Cy3-labelled experimental biological replicate and
Cy5-labelled reference pool being combined and total volume made up to 35 μl with nuclease-
free water. Scanning was performed at 5 μm resolution using an Axon GenePix 4200AL Scan-
ner (MDS Analytical Technologies, Wokingham, Berkshire, UK). Laser power was kept con-
stant (80%) and PMT adjusted for each channel so that less than 0.1% features were saturated
and the mean intensity ratio of the Cy3 and Cy5 signals was close to one. Details of the microar-
ray experiment were submitted to ArrayExpress under accession number E-MTAB-5529.
Quantitative real time PCR
Expression of candidate genes as well as genes for microarray validation was determined by
quantitative PCR (qPCR) in liver, mid and hindgut of fish from all treatments (S2 Table).
Results were normalized using reference genes, hypoxanthine phosphoribosyltransferase 1
(hprt1) and ribosomal protein L2 (rpl2), chosen as the most stable according to GeNorm (stabil-
ity number M = 0.176 and 0.184, respectively). Primers were designed using Primer 3 [21] in
regions that included the microarray probes. qPCR was performed using a Biometra TOptical
Thermocycler (Analytik Jena, Goettingen, Germany) in 96-well plates in duplicate 20 μl reac-
tion volumes containing 10 μl of Luminaris Color HiGreen qPCR Master Mix (Thermo Scien-
tific), 1 μl of the primer corresponding to the analyzed gene (10 pmol), 3 μl of molecular
biology grade water and 5 μl of cDNA, with the exception of the reference genes, which were
determined using 2 μl of cDNA. In addition, amplifications were carried out with a systematic
negative control (NTC-no template control) containing no cDNA. Standard amplification
parameters contained an UDG pre-treatment at 50˚C for 2 min, an initial activation step at
95˚C for 10 min, followed by 35 cycles: 15 s at 95˚C, 30 s at the annealing Tm and 30 s at 72˚C.
Tracking of the DsRed gene in Atlantic salmon anterior and posterior
intestine
The absence of transgenic DNA in salmon tissues was confirmed by PCR of DNA extracted
from fish midgut and hindgut. Genomic DNA was extracted using REALPURE extraction kit
(Valencia, Spain) according to the manufacturer’s instructions. Briefly, tissue samples were
incubated in 300 μl of lysis solution overnight at 55˚C with 3 μl of Proteinase K. Following
incubation, samples were cooled and RNase treatment performed (37˚C for 60 min). After
protein precipitation, DNA was precipitated by adding 600 μl of isopropanol and hydrated
with 5mM Tris. Total DNA was quantified by spectrophotometry and quality determined by
electrophoresis as described above. Two primers pairs targeting an endogenous Atlantic
salmon gene (growth hormone; gh) and a transgene marker for GM–plants (red fluorescent
protein, dsred) were used (S2 Table). Fifty ng of extracted DNA was used in PCR amplifica-
tions that were performed in a final volume of 10 μl, containing 5 μl of MyTaq™ HS Mix (Bio-
line, London, UK). Each set of PCR included a positive control (DNA from genetically
modified-Camelina) and a non-template control (NTC).
Histological evaluation
Transversal sections of liver, midgut and hindgut fixed in 4% buffered neutral-formalde-
hyde were embedded in paraffin. Four μm sections of the intestines were stained with Alcian
EPA and DHA GM-Camelina oil for salmon aquafeeds
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Blue/Periodic acid-Schiff (ABPAS) to differ between neutral/mixed and acidic mucosub-
stances in goblet cells, while liver was stained with PAS. Goblet cells (μm-2) were counted by
using the Whole Slide Manager and the Count Tool in the stereology program newCAST
(Visiopharm, Denmark). The number of neutral/mixed and acidic stained goblet cells were
counted at 40x magnification in 10% of a predefined section area within the villi. The 10%
fields of interest (FOI) were randomly selected by the program. A semi-quantitative scoring
system adapted from [22] was used to independently score six separate parameters of enteri-
tis within the proximal and distal intestines. These parameters are as follows: 1) the abun-
dance of goblet cells (GC) within the villi; 2) the degree of widening of the lamina propria
(LP) 3) the abundance eosinophilic granulocytes (EG) within the sub-epithelial mucosa
(SEM) and the degree of infiltration into the LP; 4) the thickness of the SEM and 5) the
abundance of intra-epithelial lymphocytes (IEL) within the villi. For evaluation of liver mor-
phology, the modified [23] criteria were used, including nuclear, cytoplasmic and intracyto-
plasmic evaluation. In addition, the presence of carbohydrates in PAS stained sections was
evaluated using a four grade examination scheme: 0, not observed; 1, few; 2, medium; 3,
severe. A summary of the parameters for the evaluation of both tissues is presented in S3
Table. Sections were scanned with a NanoZoomer SQ (Hamamatsu Photonics Norden,
Sweden).
Statistical analysis
All data are means ± S.D. (n = 3) unless otherwise specified. Percentage data were subjected to
arcsin square-root transformation prior to statistical analyses. Data of fish performance, biom-
etry and tissue fatty acid profiles were tested for normality and homogeneity of variances with
Levene’s test prior to one-way analysis of variance (ANOVA) followed by a Tukey-Kramer
HSD multiple comparisons of means. Data of plasma biochemistry after the challenge test
were subjected to a two-way ANOVA test after checking that data were normal and homoge-
neous. Data from the histological scoring were analysed following the chi-squared analysis for
non-parametric data. All statistical analyses were performed using SPSS software (IBM SPSS
Statistics 19; SPSS Inc., Chicago, IL, USA).
Statistical analysis of microarray hybridization data was performed in GeneSpring GX ver-
sion 12.6.1 (Agilent Technologies, Wokingham, Berkshire, UK) using a Welch (unpaired
unequal variance) t-test, at 0.05 significance given that often a fraction of the genes show
unequal variability between groups [24]. Benjamini-Hochberg multiple test correction was
employed. Data were submitted to the Kyoto Encyclopedia of Genes and Genomes (KEGG)
[25] for biological function analysis. Gene expression results were analysed using the relative
expression software tool (REST 2009; http://www.gene-quantification.info/), which employs a
pairwise fixed reallocation randomization test (10,000 randomizations) with efficiency correc-
tion to determine the statistical significance of expression ratios (gene expression fold changes)
between two treatments [26].
Results
Fish growth performance
After 12 weeks of feeding the experimental diets, fish more than doubled their weight, with no
differences in fish weight, length or other performance parameters evaluated between fish fed
the three dietary treatments (Table 2). No mortality or signs of disease were observed through-
out the experimental period.
EPA and DHA GM-Camelina oil for salmon aquafeeds
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Lipid contents and fatty acid compositions of tissues
There were no differences in total lipid contents of flesh, brain, head kidney, midgut or hind-
gut among the dietary treatments (Tables 3–5). In liver, WCO-fed fish displayed the highest
lipid contents (p< 0.05), with no difference between fish fed FO or DCO diets (Table 3). The
fatty acid compositions showed some tissue-specific differences although they all largely
reflected dietary fatty acid compositions (Tables 3–5). In this respect, muscle (flesh) of fish fed
diet DCO showed higher proportions of EPA, DPA and DHA as well as n-3 LC-PUFA and n-6
PUFA, than fish fed either FO or WCO (Table 3). This was true also in absolute terms, with
DCO-fed fish showing 931 mg of n-3 LC-PUFA per portion (130 g fillet) compared to only
587 mg and 494 mg in fish fed FO or WCO, respectively (S1 Fig). The proportions of EPA
were also significantly higher in flesh, head kidney, midgut and hindgut in fish fed DCO than
those fed the FO or WCO diets. The percentages of DHA in liver, head kidney, midgut and
hindgut were equivalent in fish fed DCO to those fed diet FO. The percentages of DPA were
significantly higher in all tissues, other than brain, in fish fed DCO compared to fish fed the
other diets. In general, dietary effect on fatty acid composition were not as pronounced in
brain as in the other tissues, with no differences among treatments in any of the totals for fatty
acid groups or DHA and DPA (Table 4). Differences were observed between midgut and hind-
gut fatty acid profiles, particularly with DHA, with no differences in levels of this fatty acid
between fish fed the three diets in midgut, whereas higher DHA levels were observed in hind-
gut of fish fed FO and DCO (Table 5).
Plasma biochemistry
Two-way ANOVA showed that the factor “time” was significant for all the parameters,
whereas significant differences with “diet” were only observed for chloride and alkaline phos-
phatase (ALP) (Table 6). Additionally an interaction between “diet” and “time” was observed
for osmolarity (p = 0.024).
Histological evaluation
There were no significant differences in the number of goblet cells (GC) among the dietary
treatments in either mid (p = 0.451) or hindgut (p = 0.369) (Table 7). No significant differences
were observed between treatment groups in GC colour in mid or hindguts. There appeared to
be a higher number of magenta GC present in midgut in DCO-fed fish, whereas the number
of these cells seemed to be higher in hindgut in fish fed WCO, albeit these trends were not sig-
nificant. No differences were observed in any of the other assessed parameters in either mid or
Table 2. Fish performance and survival over the 12-week experimental period.
FO WCO DCO
Initial weight (g) 122.4 ± 2.0 122.4 ± 2.60 122.9 ± 0.7
Initial length (cm) 22.3 ± 0.2 22.4 ± 0.2 22.3 ± 0.1
Final weight (g) 391.4 ± 8.5 406.5 ± 8.6 394.4 ± 14.4
Total length (cm) 31.5 ± 1.4 31.3 ± 1.7 31.7 ± 1.3
Survival (%) 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0
k 1.3 ± 0.0 1.3 ± 0.1 1.2 ± 0.0
SGR (%/day) 1.4 ± 0.0 1.4 ± 0.0 1.5 ± 0.1
DCO, feed containing EPA+DHA oil from transgenic camelina; FO, control (fish oil) feed; k, condition factor; SGR, specific growth rate; WCO, wild-type
camelina oil feed. There were no significant differences.
https://doi.org/10.1371/journal.pone.0175415.t002
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Table 3. Lipid contents (percentage of wet weight) and fatty acid compositions (percentage of total fatty acids) of total lipid of flesh and liver after
feeding the experimental diets for 12 weeks.
FO WCO DCO
Flesh
Lipid content 6.3 ± 0.9 5.6 ± 0.4 5.4 ± 0.8
16:0 11.5 ± 0.2a 9.6 ± 0.3c 10.6 ± 0.2b
Total saturated1 17.9 ± 0.3a 14.9 ± 0.2c 17.1 ± 0.2b
18:1n-9 25.4 ± 0.1a 17.8 ± 0.5b 12.5 ± 0.5c
Total monoenes2 47.7 ± 0.4a 33.3 ± 0.6b 23.3 ± 0.8c
18:2n-6 16.3 ± 0.4b 15.3 ± 0.0c 18.4 ± 0.1a
20:4n-6 0.3 ± 0.0b 0.2 ± 0.0b 1.5 ± 0.0a
Total n-6 PUFA3 18.2 ± 0.4b 17.9 ± 0.0b 23.0 ± 0.1a
18:3n-3 2.9 ± 0.1c 19.3 ± 0.2a 11.0 ± 0.2b
20:5n-3 2.2 ± 0.1b 1.9 ± 0.0c 4.7 ± 0.2a
22:5n-3 0.8 ± 0.0b 0.6 ± 0.0c 2.2 ± 0.0a
22:6n-3 6.8 ± 0.8b 6.2 ± 0.2b 10.4 ± 0.6a
Total n-3 PUFA4 14.2 ± 0.7b 32.6 ± 0.3a 33.5 ± 1.0a
Total PUFA 32.4 ± 0.3c 50.5 ± 0.4b 56.5 ± 1.0a
EPA + DHA 9.0 ± 0.8b 8.1 ± 0.2b 15.1 ± 0.7a
Total n-3 LC-PUFA 10.4 ± 0.7b 9.8 ± 0.3b 19.9 ± 0.8a
Liver
Lipid content 4.2 ± 0.6b 7.1 ± 1.6a 4.5 ± 0.5b
16:0 15.1 ± 1.7a 7.0 ± 0.9c 12.7 ± 1.6b
Total saturated1 21.8 ± 1.5a 12.2 ± 1.4b 20.8 ± 1.8a
18:1n-9 17.7 ± 3.5a 22.8 ± 1.0a 11.2 ± 1.4b
Total monoenes2 27.9 ± 6.5a 35.0 ± 2.0a 17.1 ± 2.3b
18:2n-6 9.9 ± 1.7b 15.4 ± 1.2a 10.5 ± 2.0b
20:4n-6 2.7 ± 0.9b 0.9 ± 0.1c 5.2 ± 0.7a
Total n-6 PUFA3 16.0 ± 0.3b 20.2 ± 1.3a 19.7 ± 1.8a
18:3n-3 1.4 ± 0.4c 14.0 ± 1.0a 5.7 ± 0.9b
20:5n-3 5.1 ± 1.4ab 3.0 ± 0.6b 6.6 ± 0.4a
22:5n-3 1.7 ± 0.2b 0.7 ± 0.2c 2.6 ± 0.2a
22:6n-3 25.0 ± 4.5a 9.1 ± 2.0b 22.9 ± 3.5a
Total n-3 PUFA4 33.9 ± 5.3ab 31.5 ± 1.8b 41.4 ± 2.6a
Total PUFA 50.0 ± 5.2b 51.7 ± 0.5b 61.1 ± 1.1a
EPA + DHA 30.1 ± 5.9a 12.1 ± 2.6b 29.4 ± 3.9a
Total n-3 LC-PUFA 32.3 ± 6.0a 14.3 ± 2.9b 34.1 ± 3.8a
Data expressed as means ± SD (n = 3). Different superscript letters within a row denote significant differences among diets. Statistical differences were
determined by one-way ANOVA with Tukey’s comparison test (p < 0.05).
1Contains 14:0, 15:0, 18:0, 20:0 and 22:0;
2Contains 16:1n-7, 18:1n-7, 20:1n-9, 22:1n-11, 22:1n-9 and 24:1;
3Contains 20:2n-6 and 20:3n-6.
4Contains 18:4n-3, 20:3n-3 and 20:4n-3.
DCO, feed containing EPA+DHA oil from transgenic Camelina; FO, fish oil feed; LC- PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3
22:5n-3 and 22:6n-3); WCO, wild-type camelina oil feed.
https://doi.org/10.1371/journal.pone.0175415.t003
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Table 4. Lipid contents (percentage of wet weight) and fatty acid compositions (percentage of total fatty acids) of total lipid of the brain and head
kidney (n = 3) after feeding the experimental diets for 12 weeks.
FO WCO DCO
Brain
Lipid content 7.4 ± 0.0 7.2 ± 0.2 7.0 ± 0.6
16:0 16.2 ± 0.4 16.0 ± 0.1 16.1 ± 0.0
Total saturated1 24.7 ± 0.9 24.1 ± 0.2 24.4 ± 0.2
18:1n-9 21.0 ± 1.1 20.8 ± 0.4 20.1 ± 0.1
Total monoenes2 33.4 ± 1.5 32.3 ± 0.8 31.6 ± 0.3
18:2n-6 2.2 ± 0.4 1.6 ± 0.6 1.7 ± 0.2
20:4n-6 1.1 ± 0.0b 1.0 ± 0.0b 1.8 ± 0.1a
Total n-6 PUFA3 3.8 ± 0.4 3.2 ± 0.5 3.9 ± 0.4
18:3n-3 0.4 ± 0.1b 1.6 ± 0.6a 0.9 ± 0.1ab
20:5n-3 5.2 ± 0.0b 5.4 ± 0.0a 5.4 ± 0.1a
22:5n-3 1.9 ± 0.2 2.0 ± 0.0 2.2 ± 0.0
22:6n-3 23.3 ± 0.9 22.6 ± 0.1 23.0 ± 0.4
Total n-3 PUFA4 31.0 ± 1.0 32.7 ± 0.8 32.4 ± 0.4
Total PUFA 34.9 ± 1.2 35.9 ± 1.3 36.4 ± 0.1
EPA + DHA 28.5 ± 0.9 28.0 ± 0.1 28.4 ± 0.4
Total n-3 LC-PUFA 30.6 ± 1.0 30.4 ± 0.1 31.1 ± 0.4
Head kidney
Lipid content 3.7 ± 0.5 3.7 ± 0.8 3.3 ± 0.3
16:0 14.2 ± 0.7 13.0 ± 1.6 13.9 ± 1.0
Total saturated1 20.9 ± 0.7 19.0 ± 1.7 21.0 ± 1.2
18:1n-9 22.6 ± 1.0a 17.4 ± 1.7b 14.4 ± 2.0b
Total monoenes2 40.0 ± 1.5a 30.1 ± 3.0b 24.6 ± 3.0b
18:2n-6 12.9 ± 0.1 12.3 ± 1.1 13.4 ± 0.6
20:4n-6 1.2 ± 0.1b 0.9 ± 0.2b 3.5 ± 0.6a
Total n-6 PUFA3 16.0 ± 0.2b 15.8 ± 0.7b 19.5 ± 0.3a
18:3n-3 2.3 ± 0.1c 13.0 ± 1.2a 6.8 ± 0.3b
20:5n-3 3.9 ± 0.5b 3.9 ± 0.7b 5.4 ± 0.3a
22:5n-3 1.0 ± 0.1b 0.9 ± 0.1b 1.9 ± 0.0a
22:6n-3 12.8 ± 1.0 12.0 ± 2.5 14.5 ± 1.3
Total n-3 PUFA4 21.2 ± 1.4b 33.8 ± 2.0a 32.5 ± 1.4a
Total PUFA 37.2 ± 1.5b 49.6 ± 1.3a 52.0 ± 1.6a
EPA + DHA 16.7 ± 1.5 15.9 ± 3.2 20.0 ± 1.6
Total n-3 LC-PUFA 18.3 ± 1.6ab 17.9 ± 3.4b 23.8 ± 1.6a
Data expressed as means ± SD (n = 3). Different superscript letters within a row denote significant differences among diets. Statistical differences were
determined by one-way ANOVA with Tukey’s comparison test (p < 0.05).
1Contains 14:0, 15:0, 18:0, 20:0 and 22:0;
2Contains 16:1n-7, 18:1n-7, 20:1n-9, 22:1n-11, 22:1n-9 and 24:1;
3Contains 20:2n-6 and 20:3n-6.
4Contains 18:4n-3, 20:3n-3 and 20:4n-3.
DCO, feed containing EPA+DHA oil from transgenic Camelina; FO, fish oil feed; LC- PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3
22:5n-3 and 22:6n-3); WCO, wild-type camelina oil feed.
https://doi.org/10.1371/journal.pone.0175415.t004
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Table 5. Lipid contents (percentage of wet weight) and fatty acid compositions (percentage of total fatty acids) of total lipid of midgut and hindgut
(n = 3) after feeding the experimental diets for 12 weeks.
FO WCO DCO
Midgut
Lipid content 5.0 ± 0.7 5.7 ± 1.3 4.4 ± 0.4
16:0 14.7 ± 0.8a 12.0 ± 1.4b 13.9 ± 0.4ab
Total saturated1 22.8 ± 1.1a 19.2 ± 1.9b 23.4 ± 0.9a
18:1n-9 19.5 ± 1.3a 16.6 ± 1.5a 12.0 ± 0.5b
Total monoenes2 35.3 ± 2.6a 29.5 ± 2.9b 20.6 ± 1.0c
18:2n-6 11.7 ± 1.2 12.5 ± 1.6 12.8 ± 1.0
20:4n-6 1.8 ± 0.2b 1.2 ± 0.4b 4.0 ± 0.3a
Total n-6 PUFA3 15.5 ± 1.0b 16.1 ± 1.1b 19.4 ± 0.9a
18:3n-3 2.1 ± 0.2c 13.1 ± 2.5a 6.5 ± 0.7b
20:5n-3 3.4 ± 0.4b 3.0 ± 0.5b 5.3 ± 0.2a
22:5n-3 1.0 ± 0.0b 0.9 ± 0.1c 1.9 ± 0.0a
22:6n-3 18.5 ± 1.7 13.9 ± 4.7 18.7 ± 2.1
Total n-3 PUFA4 25.9 ± 1.9b 34.5 ± 2.2a 35.9 ± 1.1a
Total PUFA 41.4 ± 1.0c 50.6 ± 1.1b 55.4 ± 0.4a
EPA + DHA 21.9 ± 2.1 17.0 ± 5.1 24.0 ± 2.1
Total n-3 LC-PUFA 23.2 ± 2.1ab 18.7 ± 5.0b 27.6 ± 1.9a
Hindgut
Lipid content 4.3 ± 0.4 6.1 ± 1.4 4.9 ± 0.4
16:0 13.9 ± 0.6a 11.2 ± 0.8b 12.9 ± 0.4a
Total saturated1 22.2 ± 0.7a 18.2 ± 1.4b 21.2 ± 0.7a
18:1n-9 19.2 ± 2.0a 17.1 ± 0.9a 13.3 ± 1.0b
Total monoenes2 35.0 ± 3.7a 30.6 ± 1.8a 22.9 ± 1.4b
18:2n-6 10.9 ± 1.4 12.8 ± 1.0 13.2 ± 0.7
20:4n-6 1.3 ± 0.1b 0.8 ± 0.2b 2.9 ± 0.3a
Total n-6 PUFA3 14.8 ± 1.2b 16.5 ± 0.8b 19.4 ± 0.9a
18:3n-3 2.0 ± 0.2c 13.9 ± 1.5a 6.9 ± 0.4b
20:5n-3 3.6 ± 0.5b 3.1 ± 0.6b 5.0 ± 0.3a
22:5n-3 1.8 ± 0.3b 1.5 ± 0.2b 2.6 ± 0.1a
22:6n-3 17.9 ± 2.9a 11.4 ± 2.4b 16.2 ± 0.7ab
Total n-3 PUFA4 26.3 ± 3.4b 34.2 ± 1.5a 34.9 ± 1.1a
Total PUFA 41.1 ± 2.5b 50.6 ± 0.9a 54.2 ± 1.7a
EPA + DHA 21.5 ± 3.3a 14.5 ± 3.0b 21.2 ± 0.9a
Total n-3 LC-PUFA 23.7 ± 3.5ab 17.0 ± 3.2b 25.7 ± 1.0a
Data expressed as means ± SD (n = 3). Different superscript letters within a row denote significant differences among diets. Statistical differences were
determined by one-way ANOVA with Tukey’s comparison test (p < 0.05).
1Contains 14:0, 15:0, 18:0, 20:0 and 22:0;
2Contains 16:1n-7, 18:1n-7, 20:1n-9, 22:1n-11, 22:1n-9 and 24:1;
3Contains 20:2n-6 and 20:3n-6.
4Contains 18:4n-3, 20:3n-3 and 20:4n-3.
DCO, feed containing EPA+DHA oil from transgenic Camelina; FO, fish oil feed; LC- PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3
22:5n-3 and 22:6n-3); WCO, wild-type camelina oil feed
https://doi.org/10.1371/journal.pone.0175415.t005
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hindgut. Liver of salmon fed WCO showed lower scores in terms of hepatocyte cytoplasm
(LHC; p = 0.018) and hepatic lipid intracytoplasmic vacuolization (HV; p = 0.017), with no dif-
ferences in liver nuclei (LN; p = 0.076; Table 7). Liver PAS staining also differed among fish
fed the dietary treatments with fish fed FO showing the highest score (p = 0.031).
Midgut transcriptome
In midgut, a total of 1319 genes were differentially expressed in salmon fed FO versus DCO
whereas 1135 where affected when comparing FO-fed fish with WCO-fed fish. A smaller num-
ber (924) of differentially expressed genes (DEG) was found when comparing the midgut of
salmon fed DCO against WCO-fed fish. No obvious differences were observed regarding the
intensity (fold change; FC) or direction of change (up or down-regulation) between the differ-
ent contrasts (Table 8). Restricting analysis to probes with a FC over 1.3 revealed 726 and 767
DEG in fish fed FO compared to fish fed WCO and DCO, respectively, with 148 DEG com-
mon to both contrasts (Fig 1A). Assigning KEGG Orthology (KO) numbers to these 148 com-
mon DEG and mapping them to a known compendium of metabolic pathways (KEGG)
indicated that over 59% were annotated, and showed that the metabolism category was highly
affected (33%) and, within metabolism, the main subcategories affected were carbohydrate
(9%), amino acids (6%) and lipid (5%) (Fig 1B).
The pathways with the highest numbers of DEGs in the three contrasts (FO vs. WCO, FO
vs. DCO and DCO vs. WCO) were compared (Fig 2). Although the metabolism category was
Table 7. Individual score and overall mean for the different parameter used to assess the midgut,
hindgut and the liver in Atlantic salmon fed the three experimental feeds.
FO WCO DCO
Midgut MF 1.2 ± 0.3 1.7 ± 1.2 1.7 ± 0.6
GC 1.3 ± 0.6 2.0 ± 1.0 2.2 ± 0.8
LP 1.0 ± 0.0 1.2 ± 0.3 1.0 ± 0.0
SNV 1.0 ± 0.0 1.3 ± 0.6 1.0 ± 0.0
EG 1.3 ± 0.3 1.0 ± 0.0 1.2 ± 0.3
SM 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.3
IEL 1.2 ± 0.3 1.0 ± 0.0 1.2 ± 0.3
Mean score 9.2 ± 0.3 10.3 ± 0.6 10.3 ± 1.4
Hindgut MF 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0
GC 1.0 ± 0.0 0.3 ± 0.6 1.2 ± 0.3
LP 1.0 ± 0.0 1.0 ± 0.0 1.1 ± 0.0
SNV 1.0 ± 0.0 1.8 ± 1.0 1.2 ± 0.3
EG 1.3 ± 0.3 1.0 ± 0.3 1.0 ± 0.3
SM 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0
IEL 1.2 ± 0.3 1.5 ± 0.5 1.0 ± 0.0
Mean score 8.5 ± 0.5 9.7 ± 2.1 8.8 ± 0.6
Liver LN 1.0 ± 0.0 1.7 ± 0.6 1.0 ± 0.0
LHC 1.0 ± 0.0b 1.8 ± 0.3a 1.2 ± 0.3b
HV 1.0 ± 0.0b 2.5 ± 0.5a 1.2 ± 0.3b
Glycogen 2.7 ± 0.6a 1.2 ± 0.3b 0.2 ± 0.3b
DCO, feed containing EPA+DHA oil from transgenic Camelina; EG, eosinophilic granulocytes; FO, fish oil
feed; GC, goblet cells; HV, hepatic vacuolation; IEL, intraepithelial lymphocytes; LHC, liver hepatocyte
cytoplasm; LN, liver nuclei; LP, lamina propria; MF, mucosal folds; SM, sub-epithelial mucosa; SNV,
supranuclear vacuoles; WCO, wild-type camelina oil feed.
https://doi.org/10.1371/journal.pone.0175415.t007
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highly represented, a limited number (1–9) of genes was differentially expressed in each path-
way, being most numerous in pathways related to protein metabolism such as purine and
pyrimidine metabolism. In both these pathways there was strong down-regulation in the mid-
gut of fish fed diet WCO compared to DCO-fed fish. Within the signalling category, the
PI3K-Akt signalling and cytokine-cytokine receptor interaction pathways displayed a high of
number of DEG were observed between fish fed diets containing WCO or DCO and those fed
FO. Indeed, 11 genes belonging to cytokine-cytokine receptor interactions were regulated in
the contrast FO vs. WCO, whereas only 2 and 4 were regulated in fish fed DCO compared to
FO and WCO, respectively. Most of the DEG belonged to the type I receptors family (hemato-
poietins), chemokines receptors family (subfamilies CXC and CC), as well as tumour necrosis
factor and transforming growth factor beta. Pathways that showed differences between the
three contrasts were ubiquitin mediated proteolysis and protein digestion and absorption,
which showed high numbers of down-regulated DEG when DCO-fed fish were compared to
WCO-fed fish. Within the protein digestion and absorption pathway, two membrane trans-
port proteins, solute carrier family 6 and 15, were down-regulated in DCO-fed fish compared
to fish fed WCO (-1.4 and -2.3, respectively).
To elucidate which genes in midgut were specific to DCO, 122 DEG common to both DCO
vs. FO and DCO vs. WCO contrasts were identified at a FC > 1.3 (p< 0.005; Fig 3A). After
removing non-annotated genes and duplicated genes, KEGG analysis showed that metabolism
was the main category affected (27%) followed by signalling and immune system (18% and
17%, respectively; Fig 3B). Within metabolism, lipid metabolism was the main subcategory
affected (7%). All the annotated features within the 122 commonly affected DEG are presented
in S4 Table.
Hindgut transcriptome
A similar pattern of DEG between the dietary treatments was observed in hindgut, albeit the
number of DEG was lower than in midgut at 999 (FO vs. WCO), 1289 (FO vs. DCO) and 648
(DCO vs. WCO) (Table 8). More DEG were up-regulated than down-regulated when the
Table 8. Summary of the results of midgut and hindgut microarray analysis.
FO/WCO FO/DCO DCO/WCO
Midgut
Total no. of probes 44000
Total no. of DEG 1319 924 1135
Up-regulated genes 584 (44.3%) 412 (44.6%) 576 (50.7%)
FC > 1.3 372 (63.7%) 332 (80.6%) 254 (44.1%)
Down-regulated genes 735 (55.7%) 512 (55.4%) 559 (49.3%)
FC > 1.3 354 (48.2%) 435 (85.0%) 319 (57.1%)
Hindgut
Total no. of probes 44000
Total no. of DEG 999 1289 648
Up-regulated genes 650 (65.1%) 625 (48.5%) 366 (56.4%)
FC > 1.3 563 (86.6%) 405 (64.8%) 304 (83.1%)
Down-regulated genes 349 (34.9%) 664 (51.5%) 282 (43.6%)
FC > 1.3 268 (76.8%) 462 (69.6%) 231 (81.9%)
DCO, feed containing oil from transgenic camelina; DEG, differentially expressed genes; FC, fold change;
FO, control (fish oil) feed; WCO, feed containing oil from wild-type camelina.
https://doi.org/10.1371/journal.pone.0175415.t008
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hindgut of WCO-fed fish was compared with that of fish fed FO and DCO. Restricting DEG to
those with a FC > 1.3, 831 probes were differentially expressed in the FO vs. WCO contrast,
and 867 in the FO vs. DCO contrast (Fig 4A). KEGG analysis showed that 65.0% of the DEG
were annotated. When hindgut of FO-fed fish was compared with that of fish fed either WCO
or DCO, signalling was the main category affected (40%; Fig 4B), followed by immune system
(19%). Metabolism (15%) was the next most represented category, with amino acid metabo-
lism being the main subcategory affected with lipid metabolism accounting for only 2% of the
common DEG (7%; Fig 4B).
The same pathways highly represented in the three contrasts in midgut were also observed
to have a high number of DEG in hindgut (Fig 5). Within metabolism, a strong down-regula-
tion (5 DEG) in glycerolipid and glycerophospholipid metabolism pathways was observed in
the contrast FO vs. DCO. Strong up-regulation (up to 15 genes) in pathways related to signal-
ling, cellular processes and immune system was observed in the FO vs. WCO contrast. A clear
trend in these pathways was not found in the other two contrasts. The lowest number of DEG
was observed when comparing the hindgut of fish fed WCO and DCO.
There were 92 genes commonly differentially expressed (FC > 1.3, p< 0.005) when com-
paring the hindgut of DCO-fed with fish fed either FO or WCO (Fig 6). Good agreement was
found in direction of expression between the two contrasts. KEGG analysis of these 92 DEG
revealed that 56.5% of probes were annotated, resulting in 52 features representing 29 unique
genes. The main category represented was signalling, followed by immune system and genetic
information processing, but only three genes belonging to metabolism were commonly regu-
lated in both contrasts and one of these, dimethylaniline monooxygenase, was also commonly
regulated in the midgut (S5 Table).
Fig 1. Impact of diet on midgut transcriptome of Atlantic salmon fed camelina oils (DCO and WCO) in
comparison with fish fed Fish Oil (FO). (A) Venn diagram representing mRNA transcripts differentially
expressed in the midgut of Atlantic salmon fed the experimental diets DCO and WCO compared to
diet FO. The area of the circles is scaled to the number of transcripts (Welch t-test; p < 0.05; FC > 1.3). (B)
Distribution by categories of common differentially genes in midgut between Atlantic salmon fed DCO and
WCO when compared to FO-fed fish (Welch t-test; p < 0.05; FC > 1.3). Non-annotated genes and features
corresponding to the same gene are not represented.
https://doi.org/10.1371/journal.pone.0175415.g001
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The microarray data were validated by qPCR by comparing the expression of 6 different
genes involved in metabolism in the midgut of fish fed DCO and WCO (S6 Table). Good cor-
respondence in terms of FC and direction of change (up- or down-regulated) was observed
among all the studied genes (100%). The match was also consistent in terms of significance (p
value) when comparing qPCR and microarray results (83.3%; 5 out of 6 genes).
Expression of key metabolic genes
To further focus on metabolic responses, the expression of key genes in either “candidate”
pathways or pathways found to be differentially regulated by gut microarray was investigated
by qPCR in both liver and intestinal tissues. Expression of delta-6 and delta-5 fatty acyl desa-
turases, fads2d6 and fads2d5, was down-regulated (p = 0.008 and 0.038 respectively) in liver of
fish fed DCO compared to fish fed WCO (Fig 7). There were no differences in hepatic expres-
sion of any of the fatty acid elongases evaluated. Relative expression of acetyl CoA carboxylase
(acc), phosphofructokinase (pfk) and glycogen synthase (gys) was highest in liver of fish fed
WCO, significantly so compared to fish fed FO with fish fed DCO displaying intermediate val-
ues (Fig 8). Expression of glucose-6-phosphate dehydrogenase (g6pd) was higher in liver of
Fig 2. Ranking of differentially expressed pathways in midgut of Atlantic salmon between fish fed a
feed based either on Fish Oil (FO), Wild type Camelina Oil (WCO) or EPA+DHA Camelina Oil (DCO).
Pathway analysis was performed using the Kyoto Encyclopedia of Genes and Genome (KEGG). The
area of the circle is scaled to the number of DEG within each pathway. Up-regulated genes, red; down-
regulated genes, green.
https://doi.org/10.1371/journal.pone.0175415.g002
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fish fed DCO than in liver of fish fed FO with fish fed WCO being intermediate. Other genes
of lipogenesis (fatty acid synthase, fas) and carbohydrate metabolism (glucose-6-phosphate
isomerase, gpi; glycerol kinase 5, gk5) showed no differences in liver expression between diets
(Figs 7 and 8).
The expression of genes of LC-PUFA biosynthesis were down-regulated in midgut of
salmon fed DCO, with fads2d6 and fads2d5 expression in fish fed DCO being significantly
lower than in fish fed FO or WCO (Fig 9). The same trend was observed for all the elongases
with expression of elovl2 and elovl5b being lower in midgut of fish fed DCO than fish fed FO
or WCO, respectively. Similar trends in the genes of LC-PUFA biosynthesis were observed in
hindgut, with lowest expression of fads2d6, fads2d5 and elovl2 all being lower in fish fed DCO
than fish fed the other diets, albeit not significantly (Fig 10). Expression of acc in intestinal tis-
sues was not affected by diet, whereas expression of g6pd in midgut (Fig 11A) and gk5 in hind-
gut (Fig 11B) was higher in fish fed DCO than in fish fed either of the other diets.
Detection of transgenic DNA in Atlantic salmon tissues
All salmon tissues tested negative for the presence of the camelina T-DNA gene construct, as
monitored by the use of DsRed primers, directed towards the transgene construct sequence,
whereas all tissues tested positive to salmon growth hormone gene, gh (data not shown).
Discussion
Genetic modification of oilseed crops is a feasible option to produce entirely new sources of
EPA and DHA that can replace FO in feeds without the negative effects on n-3 LC-PUFA
Fig 3. Impact of diet on midgut transcriptome of Atlantic salmon fed diets containing Fish Oil (FO) or
Wild type Camelina Oil (WCO) in comparison with fish fed the EPA+DHA Camelina Oil (DCO). (A) Venn
diagram representing transcripts differentially expressed in the midgut of Atlantic salmon fed diets FO and
WCO compared to diet DCO. The area of the circles is scaled to the number of transcripts (Welch t-test;
p < 0.05; FC > 1.3). (B) Distribution by categories of common differentially genes in midgut between Atlantic
salmon fed FO and WCO compared to DCO-fed fish (Welch t-test; p < 0.05; FC > 1.3). Non-annotated genes
and features corresponding to the same gene are not represented.
https://doi.org/10.1371/journal.pone.0175415.g003
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content of farmed fish [8]. Previous studies using oils from transgenic Camelina sativa con-
firmed that the oils could maintain fish growth and survival at equivalent levels to fish fed a
“gold standard” feed with high fishmeal and fish oil and, in addition, enhanced flesh n-3
LC-PUFA levels compared to fish fed conventional vegetable oil [11–14]. In the present study,
a lower level of fishmeal (35% of diet) was used compared to the previous trials (49%) and EPA
+ DHA levels in the control (FO) diet were around 6% compared with > 25% in previous tri-
als. Thus, the control diet in the present trial was more representative of commercial feeds,
and close to the Norwegian standard of recent years [27–28].
The EPA+DHA oil from transgenic Camelina proved to be suitable for the on-growing of
Atlantic salmon post-smolts as indicated by the good growth performance achieved by fish fed
the DCO diet. In agreement with previous studies, no differences were found in terms of per-
formance between DCO-fed fish and fish fed either FO or WCO [13–14]. Additionally, no
adverse effects were observed in fish fed DCO on any of the plasma biochemistry parameters
evaluated at the end of the feeding trial or 1 h and 24 h after the environmental stress test. Dis-
turbance of osmoregulatory capacity is a characteristic response to stress in fish [29] and typi-
cal indicators of the stress response such as elevated blood cortisol, glucose, lactate, sodium,
potassium and chloride were evident 1 h after stress in all diet groups, confirming the efficacy
of the stress challenge. However, there was little effect of diet on the response of salmon to this
particular stress test. Previous studies in gilthead sea bream (Sparus aurata) demonstrated that
Fig 4. Impact of diet on hindgut transcriptome of Atlantic salmon fed diets containing camelina oils
(WCO and DCO) in comparison with fish fed Fish Oil (FO). (A) Venn diagram representing mRNA
transcripts differentially expressed in the hindgut of Atlantic salmon fed diets WCO and DCO
compared to diet FO. The area of the circles is scaled to the number of transcripts (Welch t-test; p < 0.05;
FC > 1.3). (B) Distribution by categories of common differentially genes in hindgut between Atlantic salmon
fed WCO and DCO when compared to FO-fed fish (Welch t-test; p < 0.05; FC > 1.3). Non-annotated genes
and features corresponding to the same gene are not represented.
https://doi.org/10.1371/journal.pone.0175415.g004
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fish fed high levels of vegetable oil had higher levels of cortisol after stress and also the time for
plasma cortisol to return basal levels was greater [30–31]. However, no differences due to diet
were found among fish 1 h after being subjected to a chasing stress in Atlantic salmon fed high
levels of both plant meal and vegetable oil [32], or in sunshine bass (Morone chrysops x M. sax-
atilis) fed increasing levels of plant meals after a low-water stress challenge [33]. This could
indicate species-dependent responses to plant-based feeds and/or to different stressors. Fur-
thermore, it may be necessary to evaluate responses at intermediate points (e.g. 4 h to 6 h), as
differences in plasma biochemistry between fish fed marine- and plant-based diets have been
reported in this threshold [31].
A major consequence of sustainable feeds based on plant ingredients is reduced levels of n-
3 LC-PUFA in the flesh of farmed fish [8]. This has been demonstrated in many studies (see
[34]), and the flesh n-3 LC-PUFA content of farmed salmon has been reported recently to
have reduced by 50% over the last decade [9]. In the present study, the FO (control) feed was
formulated to reflect recent feed formulations for salmon and thus included reduced levels of
fishmeal and fish oil (replaced by rapeseed oil), which resulted in an n-3 LC-PUFA level of
around 6% of total dietary fatty acids. Replacing the added oil with the oil from transgenic
Fig 5. Ranking of differentially expressed pathways in midgut of Atlantic salmon between fish fed a
diet containing Fish Oil (FO), Wild type Camelina Oil (WCO) or EPA+DHA Camelina Oil (DCO). Pathway
analysis was performed using the Kyoto Encyclopedia of Genes and Genome (KEGG). The area of the circle
is scaled to the number of DEG within each pathway. Up-regulated genes, red; down-regulated genes, green.
https://doi.org/10.1371/journal.pone.0175415.g005
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Camelina resulted in n-3 LC-PUFA content of the DCO diet being over 17% of total fatty acids
that, in turn, doubled the n-3 LC-PUFA content of flesh of the DCO-fed fish compared to fish
fed the current commercial formulation (diet FO). Thus, substituting the fish oil/vegetable oil
blend of the commercial formulation by the new oil from transgenic Camelina has the poten-
tial to restore the n-3 LC-PUFA levels in harvest-sized salmon to levels last found a decade
ago, retaining all the positive health effects associated with consumption of farmed salmon.
Salmonids have the capability to biosynthesize LC-PUFA with liver and midgut being the
most active metabolic sites [35–36]. A common finding when Atlantic salmon are fed diets
rich in vegetable oil (high C18 PUFA, zero n-3 LC-PUFA) is up-regulated expression of hepatic
fatty acid desaturases and elongases, which in turn leads to increased production of EPA and
DHA as well as intermediate products (i.e. 20:4n-3 and 22:5n-3) [11–12; 37–39]. Fish fed the
FO and WCO diets, that had lower n-3 LC-PUFA contents than the DCO diet, showed up-reg-
ulation of hepatic fads2d6 and fad62d5 but, in the case of fish fed WCO, this was insufficient to
compensate for the low levels of n-3 LC-PUFA in this diet. In contrast, although dietary n-3
LC-PUFA levels in diet FO were intermediate between those in WCO and DCO diets, the n-3
LC-PUFA level and, especially DHA, was surprisingly similar in liver of fish fed diets FO and
DCO. The same patterns in gene expression and the proportions of DHA in liver were also
observed in mid and hindgut tissues, other tissues with active LC-PUFA biosynthesis. Suppres-
sion of fads2d6 expression by dietary DHA may be the main mechanism to inhibit n-3
LC-PUFA biosynthesis [40]. However, it was also suggested that activation of the LC-PUFA
Fig 6. Impact of diet on hindgut transcriptome of Atlantic salmon fed diets containing Fish Oil (FO) or
Wild type Camelina Oil (WCO) in comparison with fish fed fish EPA+DHA Camelina Oil (DCO). (A)
Venn diagram representing transcripts differentially expressed in hindgut of Atlantic salmon fed diets FO and
WCO compared to diet DCO. The area of the circles is scaled to the number of transcripts (Welch t-test;
p < 0.05; FC > 1.3). (B) Distribution by categories of common differentially genes in hindgut between Atlantic
salmon fed FO and WCO compared to DCO-fed fish (Welch t-test; p < 0.05; FC > 1.3). Non-annotated genes
and features corresponding to the same gene are not represented.
https://doi.org/10.1371/journal.pone.0175415.g006
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biosynthetic pathway in fish fed vegetable oil was due to both low dietary levels of the pathway
products (EPA and DHA) as well as the presence of precursor (18:3n-3) [41]. Therefore, the
impact of dietary fatty acids, other than pathway products EPA and DHA, on the expression of
desaturases and elongases may be relevant and, indeed, the level of 18:3n-3 was one of the
main differences between the three diets and this could be factor in the differences found
Fig 7. Expression of genes of the LC-PUFA biosynthesis pathway in liver of Atlantic salmon as
determined by qPCR. Results are normalized expression ratios (means ± SEM; n = 6). FO, fish oil diet;
WCO, wild type camelina oil diet; DCO, EPA+DHA camelina oil diet. fads2d6, delta-6 fatty acyl desaturase;
fads2d5, delta-5 fatty acyl desaturase; elovl2, fatty acyl elongase 2; elovl5a, fatty acyl elongase 5 isoform a;
elovl5b, fatty acyl elongase 5 isoform b; fas, fatty acid synthase. Different superscript letters denote
differences among treatments identified by one-way ANOVA.
https://doi.org/10.1371/journal.pone.0175415.g007
Fig 8. Expression of genes involved in lipogenesis and carbohydrate metabolism in liver of Atlantic
salmon as determined by qPCR. Results are normalized expression ratios (means ± SEM; n = 6). FO, fish
oil diet; WCO, wild type camelina oil diet; DCO, EPA+DHA camelina oil diet. Fas, fatty acid synthase; acc,
acetyl CoA carboxylase; gpi, glucose-6-phosphate isomerase; gys, glycogen synthase; pfk,
phosphofructokinase; pk, pyruvate kinase; g6pd, glucose-6-phosphate dehydrogenase; gk5, glycerol kinase
5.
https://doi.org/10.1371/journal.pone.0175415.g008
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between fish fed FO and WCO. It was shown previously that high levels of dietary 18:3n-3 are
actually counter-productive for maintaining n-3 LC-PUFA levels in salmon fed linseed oil
with a similar fatty acid composition to the camelina oil used in diet WCO [40]. The FO diet
had the lowest level of 18:3n-3 and the highest 18:2n-6/18:3n-3 ratio, although high levels of
this ratio did not inhibit DHA production in Atlantic salmon [41]. However, the precise
Fig 9. Expression of genes of the LC-PUFA biosynthesis pathway in midgut of Atlantic salmon as
determined by qPCR. Results are normalized expression ratios (means ± SEM; n = 6). FO, fish oil diet;
WCO, wild type camelina oil diet; DCO, EPA+DHA camelina oil diet. fads2d6, delta-6 fatty acyl desaturase;
fads2d5, delta-5 fatty acyl desaturase; elovl2, fatty acyl elongase 2; elovl5a, fatty acyl elongase 5 isoform a;
elovl5b, fatty acyl elongase 5 isoform b; fas, fatty acid synthase. Different superscript letters denote
differences among treatments identified by one-way ANOVA.
https://doi.org/10.1371/journal.pone.0175415.g009
Fig 10. Expression of genes of the LC-PUFA biosynthesis pathway in hindgut of Atlantic salmon as
determined by qPCR. Results are normalized expression ratios (means ± SEM; n = 6). FO, fish oil diet;
WCO, wild type camelina oil diet; DCO, EPA+DHA camelina oil diet. fads2d6, delta-6 fatty acyl desaturase;
fads2d5, delta-5 fatty acyl desaturase; elovl2, fatty acyl elongase 2; elovl5a, fatty acyl elongase 5 isoform a;
elovl5b, fatty acyl elongase 5 isoform b; fas, fatty acid synthase. Different superscript letters denote
differences among treatments identified by one-way ANOVA.
https://doi.org/10.1371/journal.pone.0175415.g010
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mechanism for the surprisingly high levels of DHA in liver and intestinal tissues of FO-fed fish
is unclear.
The intestine is not only the site of nutrient uptake, as the midgut also plays an active role
in LC-PUFA biosynthesis [42–43], while hindgut is involved in the uptake and transport of
antigens and final processing by intraepithelial macrophages [44]. In the present study, a
greater number of genes were regulated in midgut than in hindgut, probably reflecting the role
of midgut in digestion and nutrient metabolism. In general, all the diet contrasts presented the
same gene categories in both gut regions, suggesting similar dietary effects despite their differ-
ent physiological roles. The KO process with the highest number of DEG was amino acid
metabolism in the DCO vs WCO contrast, particularly in midgut. However, within lipid
metabolism, a high number of genes were down-regulated in the categories glycerolipid and
glycerophospholipid metabolism in fish fed DCO compared to fish fed FO, in agreement with
results found in the liver transcriptome previously [13]. In contrast, in gilthead sea bream liver
and anterior intestine the expression of lpcat1, a key player in phospholipid remodelling,
showed up-regulation or no regulation in fish fed DCO compared to FO-fed fish [14].
Although several studies have found that dietary n-3 PUFA can regulate the expression of this
enzyme in teleosts [43–47], differing results in terms of direction of regulation were observed,
indicating species differences.
Another pathway that was significantly regulated in both intestinal tissues was Cytokine-
Cytokine receptor interaction, particularly in hindgut in the FO-WCO contrast. Altered
immune system in teleosts in response to dietary vegetable oils was first reported in Atlantic
salmon [48] and since then a number of studies have reported adverse effects [49–50]. Thus,
regulation in expression of several cytokines was reported previously in the posterior intestine
of sea bream [14] and sea bass [51] fed high levels of vegetable oil. However, it is important to
note that in the present study these pathways were more affected in fish fed WCO than fish fed
DCO. Similarly, the up-regulation in several immune pathways related to apoptosis, T cell
receptor or leukocyte transendothelial migration in the hindgut of fish fed WCO compared to
Fig 11. Expression of genes involved in lipogenesis and carbohydrate metabolism in Atlantic salmon
midgut (A) and hindgut (B) as determined by qPCR. Results are normalized expression ratios
(means ± SEM; n = 6). FO, fish oil diet; WCO, wild type camelina oil diet; DCO, EPA+DHA camelina oil diet.
Fas, fatty acid synthase; acc, acetyl CoA carboxylase; gpi, glucose-6-phosphate isomerase; gys, glycogen
synthase; pfk, phosphofructokinase; pk, pyruvate kinase; g6pd, glucose-6-phosphate dehydrogenase; gk5,
glycerol kinase 5.
https://doi.org/10.1371/journal.pone.0175415.g011
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FO-fed fish was not so pronounced in fish fed DCO. All the diets in the present study con-
tained similar levels of pro-inflammatory n-6 PUFA and so it was most likely the dietary level
of n-3 LC-PUFA that influenced these effects on immune pathways with fish fed WCO, with
the lowest level of anti-inflammatory EPA and DHA, showing the greatest impact on intestinal
health. However, most studies evaluating sustainable feeds have focussed on the replacement
of fish meal by plant meals [52–53], whereas substitution of dietary lipid had had less attention.
In the present trial no adverse effects were observed on either the mid or hindgut histology.
Shorter folds in the midgut of salmon fed 80% vegetable oil were observed previously, although
no other differences in histology, immunohistochemistry or expression of immune related
genes were reported [54]. In agreement, no histological alterations were observed in intestine
of sea bass when fed 60–70% vegetable oil [55–56]. Furthermore, previous studies using an
EPA only oil from transgenic Camelina showed no intestinal alterations in either Atlantic
salmon or sea bream [12,14].
Histopathological evaluation of the liver showed enhanced intra-cytoplasmic lipid deposi-
tion in WCO-fed fish (Table 7), which was associated with increased lipid accumulation in this
tissue (Table 3) despite the lipid content of the WCO feed being slightly lower than the FO
diet. Previous studies have reported the tendency of teleosts to accumulate lipid in liver when
vegetable oils are included in feeds [11, 14; 57–58]. Concomitantly, up-regulation of the adipo-
genic enzyme acc was observed in WCO-fed fish, suggesting that the high levels of C18 fatty
acids and reduced levels of n-3 LC-PUFA enhanced the synthesis of lipids, which in turn leads
to hepatic lipid accumulation. Indeed, in mammals PUFA are known to be potent inhibitors
of de novo lipogenesis through the inhibition of acc [59]. Importantly, in the present study,
liver lipid level in fish fed DCO was restored to that of fish fed the FO diet
In the present study, reduced glycogen deposition in the liver of fish fed WCO and, espe-
cially DCO, was observed. Increased liver glycogen stores could indicate a positive energy bal-
ance [60–61] whereas reduced contents have been related to stress response [62]. In mammals,
it has been shown that n-3 LC-PUFA stimulate glycogen synthesis [63] and also regulate some
proteins involved in carbohydrate metabolism [64]. However, there are differences in nutrient
use between salmon and mammals, such as poor use of dietary glucose [60], and thus the
effects of n-3 LC-PUFA on carbohydrate metabolism in salmon are unclear. In the present
trial, DCO increased expression of g6pd consistent with previous reports using sustainable
feeds in sea bass [65]. The g6pd enzyme catalyzes NADP-linked oxidation of glucose-6-phos-
phate, and is a major provider of NADPH for lipogenesis in salmon [66]. Given that L choles-
terol biosynthesis require reducing power in the form of NADPH, increased expression of
g6pd may be related to lower levels of cholesterol in the feeds. Fish fed WCO showed the high-
est expression of the glycolytic enzyme pfk. Similarly, low dietary fish oil enhanced the activity
of pfk in the muscle of Senegalese sole [67], which could suggest the utilization of stored energy
due to the fish being in an “adverse” nutritional situation. In contrast, no effect on hepatic
expression or activity of pfk was found in rainbow trout fed diets with or without fish oil, these
fish also showing limited effects on enzymes involved in lipogenesis, fatty acid β-oxidation or
amino acid oxidation [68]. However, rainbow trout in fresh water likely have a higher capacity
to synthesize n-3 LC-PUFA and, therefore, low dietary requirements for LC-PUFA, which
could explain the reduced response compared to marine teleosts [69]. The highest expression
of glycogen synthase (gys) was also observed in WCO-fed fish, which may be a compensatory
mechanism to the increased use of glycogen as indicated by the high expression of pfk. Synthe-
sis of hepatic glycogen by glycogen synthase utilizes UDP-glucose as one substrate and the
non-reducing end of glycogen as another. De novo gluconeogenesis, probably from dietary
amino acids, has been shown in carnivorous marine fish species fed fishmeal-based (low car-
bohydrate) diets after starvation [70]. Furthermore, a direct relationship between hepatocyte
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glycogen and glycogen synthase activity was observed in rainbow trout hepatocytes incubated
with glucose indicating that the direct pathway for glycogen synthesis was active [71]. How-
ever, hepatocyte glycogen content may be controlled by several factors, including n-3
LC-PUFA levels. In this respect, feeding rats a diet containing n-3 LC-PUFA significantly
inhibited pyruvate kinase, a key glycolytic enzyme [72].
To conclude, the oil from transgenic Camelina sativa containing EPA and DHA effectively
substituted for fish oil in feeds for Atlantic salmon, supporting good growth without
compromising fish health. No adverse effects were observed on plasma biochemistry or intesti-
nal transcriptomes, and intestinal histology was normal. Furthermore, compared to fish fed
diet FO, with an n-3 LC-PUFA level similar to commercial feeds, DCO-fed fish accumulated
much higher levels of these beneficial fatty acids. Thus, the use of this entirely new source of
EPA and DHA could help to maintain or even boost the n-3 LC-PUFA in aquaculture produce
without compromising the sustainability of the feeds.
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